Our experts are available for you 24/7 in case of questions or concerns regarding Wegovy and Ozempic
Investigators to bring data on glucose management with oral orforglipron Julio Rosenstock, MD, Francesco Giorgino, MD, PhD, and other panelists will discuss results from the ACHIEVE clinical trials, including ACHIEVE-3, which compared oral semaglutide and orforglipron for use in type 2 diabetes.
Harvard scientists determined that Ozempic and Wegovy prescription holders had a seven times greater likelihood of NAION as compared to patients prescribed medications not containing semaglutide
F., Armstrong, M
Mette Gislum, Christin Lth Hertz and Thomas Bo Jensen are employees of Novo Nordisk A/S
While clinical trials are still the "gold standard," the researchers noted that Reddit community feedback reflects a different population